Rotavirus vaccine,live(Hexavalent, Sinovac)

轮状病毒疫苗（六价，科兴）

Report date: 2025/08/25 16:40:43

Base Information

Drug NameRotavirus vaccine,live(Hexavalent, Sinovac)
Drug Alias Name口服六价重配轮状病毒减毒活疫苗（Vero细胞）
ClassificationVaccines > Biological material > Viral vaccineVaccines > Development/production technology > Live attenuated vaccineVaccines > National Immunization Program > Non-immunization program vaccine(Class II) +[5] 
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsGastroenteritisRotavirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesSinovac (Dalian) Vaccine Technology Co LtdSinovac Life Sciences Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSinovac (Dalian) Vaccine Technology Co LtdSinovac Life Sciences Co Ltd
Inactive CompaniesN/A
Active IndicationsGastroenteritisRotavirus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A